Heart Health

This news channel includes content on cardiovascular disease prevention, cardiac risk stratification, diagnosis, screening programs, and management of major risk factors that include diabetes, hypertension, diet, life style, cholesterol, obesity, ethnicity and socio-economic disparities.
 

RSS icon
Incoming 2023-2024 American College of Cardiology (ACC) president Hadley Wilson, MD, shares insights on how to create health equity through both ACC programs and hospital grassroots community outreach programs. He outlines four programs his heart hospital is piloting in its community in Charlotte, North Carolina.

How cardiologists can address health disparities in their communities

Incoming 2023-2024 American College of Cardiology president Hadley Wilson, MD, shared insights on how to create health equity through grassroots community outreach programs.

Christine Seidman, MD, director of the cardiovascular genetics program, cardiovascular medicine specialist, Brigham & Women’s Hospital, discusses the use of genetics to crack the code of cardiovascular diseases to enable earlier prevention and interventions. She was named the winner of the American Heart Association (AHA) 2022 Research Achievement Award, AHA's highest honor.

VIDEO: Using genetics in cardiology to enable earlier interventions

Christine Seidman, MD, director of the cardiovascular genetics program at Brigham & Women’s Hospital, spoke to us about using genetics to crack the code of cardiovascular disease. 

Cardiovascular disease still the No. 1 cause of death in the world

A new global report, based on data from 204 different countries and territories, has been published in full in the Journal of the American College of Cardiology.

Elon Musk and Eli Lilly: How a fake tweet caused chaos and reignited the debate over insulin prices

Updated Twitter policies have helped online pranksters cause mischief in recent days, including one specific user who impersonated Eli Lilly and Company and posted that insulin was now free. Lilly's CEO has now commented on the fake tweet read 'round the world—and what it could mean for the company going forward. 

Former U.S. Surgeon General Jerome Adams (2017-2021) spoke at the opening session of the American Heart Association (AHA) 2022 Scientific Sessions last week and said cardiologists need to help end the COVID pandemic and tackle the even bigger epidemic of hypertension. He highlighted hypertension and called it a clear public health emergency, causing more than 670,000 U.S. deaths per year. #AHA22 #hypertension

Former surgeon general says cardiologists need to address hypertension and remaining COVID cases

Former U.S. Surgeon General Jerome Adams spoke at the AHA 2022 Scientific Sessions and asked cardiologists to help end the COVID pandemic and tackle the even bigger epidemic of hypertension.

Diabetes patients are experiencing fewer heart attacks and strokes as patient care continues to evolve

Patients with diabetes faced a much higher risk of a cardiovascular event in 1994 than they did in 2014, according to a new analysis published in JAMA.

New evidence that heart damage risk is much higher after COVID-19 infection than after vaccination

The new meta-analysis, published in Frontiers in Cardiovascular Medicine, included data from 58 million patients. “We hope our findings will help mitigate vaccine hesitancy and increase vaccine uptake," one researcher said. 

Myocarditis risk higher after COVID-19 infection than after vaccination, new study of 43 million patients confirms

The new analysis, published in Circulation, confirmed that vaccine-related myocarditis is incredibly rare.

Displaying 33 - 40 of 58

Around the web

Cardiovascular Business
FDA says years-long tirzepatide shortage is resolved, will give limited leeway to compounders

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

AI in Healthcare
From Capitol Hill to a hospital near you? 5 federal recommendations for healthcare AI policy

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Cardiovascular Business
Merck spends up to $2B to license new weight loss drug with potential heart benefits

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.